Home » Pharma Blog Watch
Pharma Blog Watch
September 11, 2006
Adverse Drug Reactions
(Drug Injury Watch)
Continuing his series on adverse drug reactions, blogger Tom Lamb writes about
drug-safety monitoring, including how a new collaboration between the FDA and
the Massachusetts Institute of Technology to develop an automated system will
be an improvement over MedWatch.
PDUFA Fees (Eye on FDA)
In his blog, Mark Senak discusses Prescription Drug User Fee Act (PDUFA) fees,
which he believes will only continue to increase. "The current environment,
colored by the post-Vioxx mentality, is likely to produce many more mandates,"
and more enforcement will require more funding, he writes.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct